Literature DB >> 2034674

Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences.

L Han1, J S Yun, T E Wagner.   

Abstract

Recombinant plasmids pLP psi as and pCP psi as were constructed by positioning the Moloney murine leukemia virus (M-MuLV) proviral packaging (psi) sequences in reverse orientation under the transcriptional regulation of lymphotropic promoter/regulatory elements from the M-MuLV long terminal repeat or the cytomegalovirus immediate-early region. Linear fragments containing the antisense psi and the appropriate transcriptional regulatory sequences from these plasmids were introduced into the mouse germ line by zygote microinjection. The chromosomal integration, germ-line transmission, and lymphocyte-directed expression of the antisense psi RNA were confirmed. Control (nontransgenic) and transgenic mice containing either the pLP psi as or the pCP psi as sequences were infected with M-MuLV on the day of birth and assayed for signs of leukemia between 12 and 14 weeks of age with standard assay procedures. While 31% (11 of 36) of the control, nontransgenic, mice developed leukemia, none of the antisense psi transgenic mice developed any symptoms of leukemia. The pCP psi as sequences were also introduced into mouse NIH 3T3 cells and stably transformed cell lines were isolated. When infected with M-MuLV these cells were shown to produce virus devoid of packaged viral RNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2034674      PMCID: PMC51649          DOI: 10.1073/pnas.88.10.4313

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Expression of human class II major histocompatibility complex antigens using retrovirus vectors.

Authors:  A J Korman; J D Frantz; J L Strominger; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 3.  Antisense RNA: its functions and applications in gene regulation--a review.

Authors:  M Inouye
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

4.  Transcriptional control of the endogenous MYC protooncogene by antisense RNA.

Authors:  K Yokoyama; F Imamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 6.  Reverse transcription.

Authors:  H Varmus
Journal:  Sci Am       Date:  1987-09       Impact factor: 2.142

7.  Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region.

Authors:  M A Bender; T D Palmer; R E Gelinas; A D Miller
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

9.  Enhanced reactivity in mixed leukocyte cultures after separation of mononuclear cells on Ficoll-Hypaque.

Authors:  B Bain; K Pshyk
Journal:  Transplant Proc       Date:  1972-06       Impact factor: 1.066

10.  Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice.

Authors:  M M McGrane; J de Vente; J Yun; J Bloom; E Park; A Wynshaw-Boris; T Wagner; F M Rottman; R W Hanson
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

View more
  11 in total

1.  Therapeutic effect of a Gag-nuclease fusion protein against retroviral infection in vivo.

Authors:  G Schumann; M Hermankova; K Cannon; J L Mankowski; J D Boeke
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  Antisense and ribozyme constructs in transgenic animals.

Authors:  D L Sokol; J D Murray
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

Review 3.  Antiviral ribozymes. New jobs for ancient molecules.

Authors:  A Menke; G Hobom
Journal:  Mol Biotechnol       Date:  1997-08       Impact factor: 2.695

Review 4.  Transgenic cell lines for detection of animal viruses.

Authors:  P D Olivo
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model.

Authors:  M Andäng; J Hinkula; G Hotchkiss; S Larsson; S Britton; F Wong-Staal; B Wahren; L Ahrlund-Richter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  RNA enzyme-directed gene therapy.

Authors:  S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

7.  Protection of shrimp Penaeus monodon from WSSV infection using antisense constructs.

Authors:  Sajad Ahanger; Supriyanka Sandaka; Deepika Ananad; Madhu K Mani; Ravinder Kondadhasula; Chandra Sekhar Reddy; Makesh Marappan; Rajendran K Valappil; Kshitish C Majumdar; Rakesh K Mishra
Journal:  Mar Biotechnol (NY)       Date:  2013-08-03       Impact factor: 3.619

8.  Reduced beta 2-microglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme.

Authors:  S Larsson; G Hotchkiss; M Andäng; T Nyholm; J Inzunza; I Jansson; L Ahrlund-Richter
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

9.  Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression.

Authors:  G H Cantor; T F McElwain; T A Birkebak; G H Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines.

Authors:  L Q Sun; D Warrilow; L Wang; C Witherington; J Macpherson; G Symonds
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.